Abilify© Lawsuit Information

Abilify Injury Claims

The FDA approved Abilify to treat schizophrenia in 2002, but its list of approved uses has grown over the years including:

  • Autism-associated irritability
  • Bipolar disorder
  • Major depressive disorder
  • Schizophrenia
  • Tourette’s disorder

Hundreds of people claimed in Abilify lawsuits they suffered compulsive behavior after taking the drug. Some of the lawsuits claim people lost their life savings due to the drug’s side effects.

They claimed Abilify side effects caused them to compulsively gamble, eat or spend money. Others said they suffered involuntary movement, hypersexual activity and suicidal behavior.

In 2016, a federal panel combined 22 lawsuits over Abilify into a multidistrict litigation (MDL). MDLs let federal courts combine similar cases to move more efficiently through the legal process. As of August 2018, there were 1,665 Abilify lawsuits in the MDL.

The drug’s manufacturers agreed to settle three bellwether lawsuits for undisclosed amounts just before they were scheduled for trial in April 2018.In June 2018, the court ordered new cases selected for future bellwethers. Starting with 100 potential cases, the court narrowed the list to just 40 by August 2018. Attorneys on both sides are in a process of selecting which cases to keep or remove from the list. The judge ordered that they narrow the list to just 10 cases by December 2018. Some of those cases could go to trial sometime in 2019 if there is no settlement.

1-800-557-3304
Build Your Practice With

Mass Tort Leads

Strict Adherence to Intake Criteria

We strictly adhere to the intake criteria applicable to each product or device to ensure quality and maximize return on investment.

Strict Compliance

We take compliance seriously to ensure that you have no regulatory issues.

No Hidden Fees Ever

We never charge any set up or marketing fees beyond the actual lead cost.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram